Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates

mBio(2024)10.1128/mbio.02913-24Source: DataRank Database

Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates is a research paper published in mBio (2024). On theSindex it has a DataRank of 0.292. It has been cited 6 times.

N/A

0.292DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 1.05)OA: goldTopics (82)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.292

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Do-Kyun Kim ORCID,Soowon Kang ORCID,Chih‐Jen Lai ORCID,In–Ho Cha ORCID,Pei‐Ching Chang ORCID

Live enrichment

PubMed:39475238 PMC:PMC11633179 OpenAlex:https://openalex.org/W4403889011

HHS | National Institutes of Health

Grant: CA251275, CA294881, AI152190, AI17120, AI181758, DE023926, DE028521

National Science and Technology Council

Grant: 109-2926-I-010-503

NIDCR NIH HHS

Grant: R01 DE028521

NCI NIH HHS

Grant: R01 CA251275

NIDCR NIH HHS

Grant: R01 DE023926

NIAID NIH HHS

Grant: R01 AI152190

NCI NIH HHS

Grant: U01 CA294881

NIAID NIH HHS

Grant: R01 AI181758

National Institutes of Health

Grant: 1R01AI152190-01

Tickborne SFTS Virus Vaccine Development

National Institutes of Health

Grant: 5R01AI017120-05

HUMAN TL (HTL) REGION IN THE HLA LINKAGE GROUP

National Institutes of Health

Grant: 5R01CA251275-02

Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor

National Institutes of Health

Grant: 5R01DE023926-10

KSHV Epigenetic Regulation

National Institutes of Health

Grant: 5U01CA294881-02

Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study

National Institutes of Health

Grant: 1R01AI181758-01A1

KSHV-mediated metabolic reprogramming for LANA expression and viral persistency

FWCI

1.05

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://journals.asm.org/doi/pdf/10.1128/mbio.02913-24?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.02913-24?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.02913-24

journalhttps://doi.org/10.1128/mbio.02913-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39475238

Fields of Study

Viral-associated cancers and disordersCytomegalovirus and herpesvirus researchParvovirus B19 Infection Studies0301 basic medicine03 medical and health sciencesAnimalsMiceHerpesvirus 8, HumanAntibodies, ViralDisease Models, AnimalViral Envelope ProteinsFemaleVaccine DevelopmentRhadinovirusNanoparticlesHumansHerpesviridae InfectionsImmunogenicity, VaccineHerpesvirus VaccinesVaccine EfficacyViral VaccinesMice, Inbred C57BLSarcoma, KaposiLiposomesViral Proteins

MeSH Terms

Immunogenicity, VaccineVaccine DevelopmentVaccine EfficacyAnimalsAntibodies, ViralDisease Models, AnimalFemaleHerpesviridae InfectionsHumansLiposomesMice, Inbred C57BLSarcoma, KaposiViral Envelope ProteinsViral ProteinsViral VaccinesRhadinovirusHerpesvirus 8, HumanHerpesvirus VaccinesMiceNanoparticles

Keywords

VirologyImmunogenicityBiologyVector (molecular biology)Kaposi's sarcoma-associated herpesvirusVaccinationImmunologyImmune systemVirusGeneHerpesviridaeViral diseaseVaccinesMhv68RhadinovirusVaccine EfficacyHerpesvirus VaccinesAntibodies, ViralMicrobiologyMiceViral ProteinsImmunogenicity, VaccineViral Envelope ProteinsVaccine DevelopmentAnimalsHumansSarcoma, KaposiViral VaccinesHerpesviridae InfectionsQR1-502Mice, Inbred C57BLDisease Models, AnimalHerpesvirus 8, HumanLiposomesNanoparticlesFemaleResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being

Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates

FAIR Checklist

DataRank Breakdown

Authors (7)

Funding (14 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)